Rabade Nikhil, Mansukhani Dia, Khodaiji Shanaz, Padte Balkrishna, Bhave Abhay, Tembhare Prashant, Subramanian Papagudi Ganesan, Sehgal Kunal
Hematology Laboratory, P. D. Hinduja National Hospital, Mumbai, Maharashtra, India.
Indian J Pathol Microbiol. 2015 Jan-Mar;58(1):108-12. doi: 10.4103/0377-4929.151204.
Large granular lymphocytes (LGL) leukemias are commonly of the T-cell or NK-cell type. T-cell LGL leukemia is typically a disorder of mature CD3, CD8 and T-cell receptor TCR (TCR - T cell receptor)-αβ positive cytotoxic T-cells. Rare variants include TCRγδ+ variants and CD4 + TCRαβ+ cases. We report a case of each of these rare variants. An 83-year-old female presented with anemia and lymphocytosis with LGLs on peripheral smear. Six-color multiparametric flowcytometric analysis showed expression of CD3, heterogeneous CD7, dim CD2 and TCRγδ and lacked expression of CD5, TCRαβ, CD56, CD4 and CD8. A final diagnosis of TCRγδ+ T-cell LGL leukemia was made. Differentiation between TCRγδ+ T-cell LGL leukemia and other γδ+ T-cell malignancies is of utmost importance due to the indolent nature of the former as compared to the highly aggressive behavior of the latter. An 85-year-old male diagnosed with liposarcoma was identified to have lymphocytosis during preoperative evaluation. Peripheral smear showed presence of LGLs. Flowcytometric immunophenotyping showed expression of TCRαβ, CD3, CD2, CD5, CD4, dim CD8, CD56 with aberrant loss of CD7 expression. Vβ repertoire analysis by flowcytometry showed 97% cells with Vβ14 clonality. A final diagnosis of TCRαβ+ CD4 + T-cell LGL leukemia was made. CD4 + T-cell large granular lymphocytic leukemias have an indolent, less aggressive course when compared to their CD8 + counterparts and are not necessarily associated with cytopenias. However, their association with secondary neoplasia (29% of the cases) warrants a high degree of suspicion in the diagnosis as also noted in the index case. Use of a wide panel of antibodies and newer modalities such as Vβ repertoire analysis helps in accurate subtyping of LGL leukemia.
大颗粒淋巴细胞(LGL)白血病通常为T细胞或NK细胞类型。T细胞LGL白血病通常是成熟的CD3、CD8和T细胞受体TCR(TCR - T细胞受体)-αβ阳性细胞毒性T细胞的一种疾病。罕见变异包括TCRγδ+变异型和CD4 + TCRαβ+病例。我们报告了这两种罕见变异型的各一例病例。一名83岁女性因外周血涂片出现贫血和淋巴细胞增多伴LGL而就诊。六色多参数流式细胞术分析显示CD3、异质性CD7、弱阳性CD2和TCRγδ表达,而CD5、TCRαβ、CD56、CD4和CD8无表达。最终诊断为TCRγδ+ T细胞LGL白血病。由于TCRγδ+ T细胞LGL白血病的惰性本质与其他γδ+ T细胞恶性肿瘤的高度侵袭性行为相比,区分TCRγδ+ T细胞LGL白血病与其他γδ+ T细胞恶性肿瘤至关重要。一名85岁男性在术前评估时被诊断为脂肪肉瘤,发现有淋巴细胞增多。外周血涂片显示有LGL存在。流式细胞术免疫表型分析显示TCRαβ、CD3、CD2、CD5、CD4、弱阳性CD8、CD56表达,CD7表达异常缺失。流式细胞术Vβ谱分析显示97%的细胞具有Vβ14克隆性。最终诊断为TCRαβ+ CD4 + T细胞LGL白血病。与CD8 + T细胞大颗粒淋巴细胞白血病相比,CD4 + T细胞大颗粒淋巴细胞白血病病程惰性、侵袭性较小,且不一定与血细胞减少相关。然而,正如索引病例中所指出的,它们与继发性肿瘤的关联(29%的病例)在诊断时需要高度怀疑。使用广泛的抗体组合和更新的方法如Vβ谱分析有助于准确对LGL白血病进行亚型分类。